| 000 | 01532 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513190235.0 | ||
| 264 | 0 | _c20000124 | |
| 008 | 200001s 0 0 eng d | ||
| 022 | _a1075-2765 | ||
| 024 | 7 |
_a10.1097/00045391-199711000-00013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSepúlveda, C | |
| 245 | 0 | 0 |
_aEnhancement of natural killer cell activity in HIV-1-infected subjects by a mixture of the calcium ionophore A23187 and the phorbol ester TPA: lack of response to a similar challenge with interleukin-2 or alpha-interferon. _h[electronic resource] |
| 260 |
_bAmerican journal of therapeutics _c |
||
| 300 |
_a413-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _ximmunology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCalcimycin _xpharmacology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHIV-1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-2 _xpharmacology |
| 650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 700 | 1 | _aPuente, J | |
| 700 | 1 | _aWeinstein, C | |
| 700 | 1 | _aWolf, M E | |
| 700 | 1 | _aMosnaim, A D | |
| 773 | 0 |
_tAmerican journal of therapeutics _gvol. 4 _gno. 11-12 _gp. 413-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00045391-199711000-00013 _zAvailable from publisher's website |
| 999 |
_c10381600 _d10381600 |
||